Intratympanic gentamicin therapy for Ménière's disease: A meta-analysis

Otology and Neurotology

Volumn 25, Issue 4, 2004, Pages 544-552

  Chia, Stanley H ^a   Gamst, Anthony C ^a   Anderson, John P ^b   Harris, Jeffrey P ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Division of Otolaryngology   (United States)

Author keywords

Gentamicin therapy; Intratympanic; M ni re's disease; Therapy

Indexed keywords

GENTAMICIN;

ANTIBIOTIC THERAPY; CALORIC VESTIBULAR TEST; CATHETER; DRUG DELIVERY SYSTEM; HEARING LOSS; HUMAN; INJECTION; LOW DRUG DOSE; MENIERE DISEASE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; TITRIMETRY;

ANTI-BACTERIAL AGENTS; CATHETER ABLATION; GENTAMICINS; HEARING LOSS; HUMANS; MENIERE'S DISEASE; TREATMENT OUTCOME; VERTIGO; VESTIBULE;

EID: 4043123470     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200407000-00023     Document Type: Review

References (33)

1. Thomsen J, Charabi S, Tos M. Preliminary results of a new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur Arch Otorhinolaryngol 2000;257:362-5.
2. Hoffer ME, Kopke RD, Weisskopf P, Gottshall K, Allen K, Wester D. Microdose gentamicin administration via the round window microcatheter. Ann N Y Acad Sci 2001;942:46-51.
3. Schoendorf J, Neugebauer P, Michel O. Continuous intratympanic infusion of gentamicin via a microcatheter in Meniere's disease. Otolaryngol Head Neck Surg 2001;124:203-7.
4. Schuknecht HF. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol 1957;132(Suppl):1-42.
5. Nedzelski JM, Bryce GE, Pfleiderer AG. Treatment of Meniere's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992;21:95-101.
6. Rauch SD, Oas JG. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report. Laryngoscope 1997;107:49-55.
7. Pfleiderer AG. The current role of local intratympanic gentamicin therapy in the management of unilateral Meniere's disease. Clin Otolaryngol 1998;23:34-41.
8. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Meniere's disease. Am J Otol 1998;19:435-42.
9. Pearson WP, Brackmann DE. Committee on hearing and equilibrium: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
10. Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Meniere. Arch Otorhinoloryngol 1978;221:149-52.
11. Lehmann E, Cassella G. Theory of Point Estimation. New York: Springer, 1998.
12. McCullagh P, Nelder J. Generalized Linear Models. London: Chapman & Hall, 1989.
13. Harrell F. Regression Modeling Strategies. New York: Springer, 2001.
14. McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ. Intratympanic gentamicin treatment of Meniere's disease. Otolaryngol Head Neck Surg 1998;118:589-96.
15. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Laryngoscope 2000;110:1298-305.
16. Nedzelski JM, Fradet G, Bryce GE. Intratympanic gentamicin instillation as treatment of unilateral Meniere's disease: update of an ongoing study. Am J Otol 1993;14:278-82.
17. Corsten M, Marsan J, Schramm D, Robichaud J. Treatent of intractable Meniere's disease with intratympanic gentamicin: review of the University of Ottawa experience. J Otolaryngol 1997;26:361-4.
18. Sennaroglu L, Sennaroglu G, Gursel B, Mottaghian F. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease. Otolaryngol Head Neck Surg 2001;125:537-43.
19. Toth AA, Parnes LS. Intratympanic gentamicin therapy for Meniere's disease: preliminary comparison of two regimens. J Otolaryngol 1995;24:340-4.
20. Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Meniere's disease. Am J Otol 1999;20:357-63.
21. Magnusson M, Padoan S. Delayed onset of ototoxic effects of gentamicin in treatment of Meniere's disease. Acta Otolaryngol 1991;111:671-6.
22. Quaranta A, Aloisi A, De Benedittis G, Scaringi A. Intratympanic therapy for Meniere's disease. Ann N Y Acad Sci 1999;884:410-24.
23. Quaranta A, Scaringi A, Aloisi A, Quaranta N, Salonna I. Intratympanic therapy for Meniere's disease: effect of administration of low concentration of gentamicin. Acta Otolaryngol 2001;121:387-92.
24. Driscoll CLW, Kasperbauer JL, Facer GW, Harner SG, Beatty CW. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Laryngoscope 1997;107:83-9.
25. Harner SG, Driscoll CLW, Facer GW, Beatty CW, McDonald TJ. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol Neurotol 2001;22:210-4.
26. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympnaic injection therapy in Meniere's disease. Otol Neurotol 2002;23:494-503.
27. Longridge NS, Mallinson AI. Low-dose intratympanic gentamicin treatment for dizziness in Meniere's disease. J Otolaryngol 2000;29:35-9.
28. Seidman M. Continuous gentamicin therapy using an IntraEAR microcatheter for Meniere's disease: a retrospective study. Otolaryngol Head Neck Surg 2002;126:244-56.
29. Odkvist LM. Middle ear ototoxic treatment for inner ear disease. Acta Otolaryngol 1988;457:83-6.
30. Beck C. Intratympanic application of gentamicin for treatment of Meniere's disease. Keio J Med 1986;35:36-41.
31. Minor LB. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Am J Otol 1999;20:209-19.
32. Hirsch BE, Kamerer DB. Intratympanic gentamicin therapy for Meniere's disease. Am J Otol 1997;18:44-51.
33. Laitakari K. Intratympanic gentamycin in severe Meniere's disease. Clin Otolaryngol 1990;15:545-8.